comprehensive -WSS

comprehensive

author：focus 2025-09-05 08:03:31 - browse：936

Two researchers look at a computer monitor showing a graph and other data — Adobe

Research universities are voicing concerns over some proposed changes to the process for reviewing scientific misconduct allegations, citing worries that new government requirements would hobble their own independent procedures and constitute a huge administrative burden.

Nearly two decades since it last released research misconduct rules, the U.S. Office of Research Integrity (ORI) is ready to update its requirements for ensuring the scientific standards of projects funded by the U.S. Department of Health and Human Services, including the National Institutes of Health.

The proposed changes, published on Oct. 6, include a new formal process that institutions would follow in reviewing allegations, a 30-day deadline for institutions to assess allegations, and provisions that make it harder to quickly dismiss cases that institutions believe to be “honest errors.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： Nurses recount patients attacks

WSS

BMS, looking to build heart drug business, turns to AI for diagnosis

Be careful with at

Novo Nordisk touts Wegovy study, but still struggling with supply

Timeline: How the deadly wildfires took over Maui day by day

Gene editing the human germline: What are the risks?

Biden administration begins canceling student loan debt for 804,000 borrowers

hotspot

comprehensive

focus

Medicare details structure of new drug price negotiation program

Illinois Supreme Court finds assault weapons ban constitutional

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Dozens dead from Maui wildfires: What we know about the victims

BioMarin wins approval for gene therapy to treat hemophilia A

Asbestos, a deadly carcinogen, banned by EPA

BioMarin wins approval for gene therapy to treat hemophilia A

Physicians and social media: If you see something, say something?

Novavax promises a turnaround & Lilly roils the obesity market

Creating egg and sperm cells from stem cells raises ethical issues

entertainment

Gene editing the human germline: What are the risks?

Treatments for cramps don't cut it. Why aren't there better options?

Sweeping indictment could be Trump's biggest legal challenge yet: ANALYSIS

What to know about the judge who will handle the Trump case

Indictment alleges Trump's ex

Baby aspirin cuts fat buildup in liver disease patients, in small study

Wikipedia

hotspot

leisure time

hotspot